“Brillient Corporation has been recently awarded a contract with The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to provide technical services and administrative support. This is a delivery order against Brillient’s GSA, PSS Schedule, with a three year period of performance, and a total contract ceiling of $9,184,581.84 The contract focuses on enhancing the NIDDK mission to conduct and support medical research, research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, obesity, kidney, urologic and hematologic diseases, to improve people’s health and quality of life…” Read the full press release here.
Source: Brillient awarded technical and administrative contract with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) – September 26, 2018. Brillient.
